By David Wild
A number of clinical pharmacy changes made during the COVID-19 pandemic could potentially continue after the health emergency subsides, but one expert called for more evidence examining the impact of new models like “virtual rounding” and drive-up international normalized ratio (INR) testing.
NOVEMBER 18, 2021